A critical discovery in cancer study is emerging with the use of VHH fragments to re-engage mutated p53. This vital cancer suppressor protein is frequently disabled in many forms of tumors, resulting uncontrolled https://socialbookmarkgs.com/story21969150/nanobodies-restore-tumor-suppressor-p53-a-new-approach-for-cancer-therapy